BioCentury
ARTICLE | Finance

ASCO and Beyond

Buyside stock picks for 2Q11: ASCO plays, Phase III data, product launches

April 4, 2011 7:00 AM UTC

The second quarter docket is full of clinical and regulatory milestones, as well as early reports of sales for a number of newly launched products.

Foremost among the events this quarter is the American Society of Clinical Oncology meeting June 3-7 in Chicago. The meeting abstracts are due to be posted on May 18, but Kurt von Emster of venBio expects investors will start looking at ASCO plays relatively early in the quarter...